دورية أكاديمية
أعرض في EDS

Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort.

التفاصيل البيبلوغرافية
العنوان: Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort.
المؤلفون: Feter N; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil., Caputo EL; Universidade Federal de Pelotas, Pelotas, Brasil., Leite JS; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil., Delpino FM; Universidade Federal de Pelotas, Pelotas, Brasil., Silva LSD; Universidade Federal de Pelotas, Pelotas, Brasil., Vieira YP; Universidade Federal do Rio Grande, Rio Grande, Brasil., Paz IA; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil., Rocha JQS; Universidade Federal do Rio Grande, Rio Grande, Brasil., Silva CND; Universidade Federal do Rio Grande, Rio Grande, Brasil., Schröeder N; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil., Silva MCD; Universidade Federal de Pelotas, Pelotas, Brasil., Rombaldi AJ; Universidade Federal de Pelotas, Pelotas, Brasil.
المصدر: Cadernos de saude publica [Cad Saude Publica] 2023 Dec 11; Vol. 39 (12), pp. e00098023. Date of Electronic Publication: 2023 Dec 11 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Escola Nacional De Saúde Pública, Fundação Oswaldo Cruz Country of Publication: Brazil NLM ID: 8901573 Publication Model: eCollection Cited Medium: Internet ISSN: 1678-4464 (Electronic) Linking ISSN: 0102311X NLM ISO Abbreviation: Cad Saude Publica Subsets: MEDLINE
أسماء مطبوعة: Publication: <2012->: Rio De Janeiro : Escola Nacional De Saúde Pública, Fundação Oswaldo Cruz
Original Publication: Rio de Janeiro : A Escola,
مواضيع طبية MeSH: Post-Acute COVID-19 Syndrome* , COVID-19*/epidemiology, Adult ; Male ; Humans ; Female ; Child ; Brazil/epidemiology ; Pandemics ; Prevalence ; SARS-CoV-2
مستخلص: Most COVID-19 survivors have reported experiencing persistent symptoms after the infection - these types of cases are known as long COVID. Since Brazil was an epicenter of the COVID-19 pandemic, a high burden of long COVID is expected. This study aimed to identify the prevalence and factors associated with long COVID in adults in Southern Brazil, analyzing data from the PAMPA cohort. Participants filled out a self-reported online questionnaire in June 2022. This study only included subjects who tested positive for COVID-19. Long COVID was defined by any symptoms that persisted for at least three months after the SARS-CoV-2 infection. Poisson's regression models with robust variance were used to identify factors associated with long COVID; and results were reported as prevalence ratios (PR) and respective 95% confidence intervals (95%CI). A total of 1,001 participants (77.4% women, mean age [SD] = 38.3 [11.9] years) were analyzed. The prevalence of long COVID among these patients was 77.4% (95%CI: 74.7; 79.9). The likelihood of long COVID was higher in unvaccinated participants (PR = 1.23, 95%CI: 1.06; 1.42), in those with chronic conditions (PR = 1.13, 95%CI: 1.04; 1.24), and in those who were hospitalized due to the COVID-19 infection (PR = 1.24, 95%CI: 1.16; 1.32). This prevalence was also higher in women (PR = 1.21, 95%CI: 1.09; 1.33) than in men. Physical activity was associated with a reduced likelihood of fatigue, neurological complications, coughing, and headaches as persistent symptoms after a COVID-19 infection. It was found that three out of four adults in Southern Brazil experienced long COVID. Public policies aiming to reduce the burden of long COVID must be prioritized, especially in groups that are at higher risk of developing this harmful condition.
References: J Clin Med. 2022 Jan 14;11(2):. (PMID: 35054108)
Lung. 2021 Apr;199(2):113-119. (PMID: 33569660)
Global Health. 2020 Jul 6;16(1):57. (PMID: 32631403)
Infect Control Hosp Epidemiol. 2023 Jun 05;:1-7. (PMID: 37272468)
Nat Commun. 2022 Oct 12;13(1):5663. (PMID: 36224173)
BMJ. 2022 May 18;377:e069676. (PMID: 35584816)
JAMA Intern Med. 2023 Jun 1;183(6):566-580. (PMID: 36951832)
Br J Gen Pract. 2022 Jan 27;72(715):70. (PMID: 35091402)
EClinicalMedicine. 2022 Dec 01;55:101762. (PMID: 36474804)
Lancet Glob Health. 2020 Nov;8(11):e1390-e1398. (PMID: 32979314)
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27285-27291. (PMID: 33060298)
Lancet. 2023 Sep 30;402(10408):1115-1117. (PMID: 37652071)
BMJ Med. 2023 Feb 1;2(1):e000229. (PMID: 36910458)
J Infect Public Health. 2023 May;16(5):660-672. (PMID: 36931142)
Sports Med. 2021 Aug;51(8):1673-1686. (PMID: 33877614)
Sci Rep. 2022 May 25;12(1):8801. (PMID: 35614108)
Br J Sports Med. 2022 Aug 22;:. (PMID: 35995587)
Intern Emerg Med. 2023 Aug;18(5):1573-1581. (PMID: 36449260)
Diabetes Res Clin Pract. 2020 Aug;166:108293. (PMID: 32623035)
World Health Organ Tech Rep Ser. 1995;854:1-452. (PMID: 8594834)
Sci Rep. 2023 Jan 5;13(1):215. (PMID: 36604523)
Nat Rev Immunol. 2023 Oct;23(10):618-634. (PMID: 37433988)
Nat Rev Endocrinol. 2019 Jul;15(7):383-392. (PMID: 30837717)
PLoS One. 2021 Jul 12;16(7):e0254523. (PMID: 34252157)
Brain Behav Immun. 2022 Mar;101:93-135. (PMID: 34973396)
Nat Commun. 2022 Jun 28;13(1):3528. (PMID: 35764621)
J Infect Dis. 2022 Nov 1;226(9):1593-1607. (PMID: 35429399)
Int J Environ Res Public Health. 2022 Apr 22;19(9):. (PMID: 35564488)
Int J Environ Res Public Health. 2022 Feb 16;19(4):. (PMID: 35206434)
PLoS One. 2022 Nov 23;17(11):e0277317. (PMID: 36417364)
Infection. 2022 Feb;50(1):285-286. (PMID: 34519974)
PLoS One. 2021 Mar 4;16(3):e0247461. (PMID: 33661992)
Age Ageing. 2016 Nov;45(6):747-748. (PMID: 27555047)
Med Sci Sports Exerc. 2019 Jun;51(6):1242-1251. (PMID: 31095081)
Sci Rep. 2021 Aug 9;11(1):16144. (PMID: 34373540)
New Gener Comput. 2021;39(3-4):623-645. (PMID: 33746335)
BMC Med Res Methodol. 2003 Oct 20;3:21. (PMID: 14567763)
J Phys Act Health. 2020 Nov 03;17(12):1275-1284. (PMID: 33152693)
تواريخ الأحداث: Date Created: 20231213 Date Completed: 20231216 Latest Revision: 20231216
رمز التحديث: 20231217
مُعرف محوري في PubMed: PMC10715571
DOI: 10.1590/0102-311XEN098023
PMID: 38088735
قاعدة البيانات: MEDLINE
الوصف
تدمد:1678-4464
DOI:10.1590/0102-311XEN098023